Honoring the Moscow Commitment, Renhe Capsule Deepens Cooperation in the Russian Market Through Continuous Innovation

From November 25 to 28, 2025, the PharmTech & Ingredients 2025 exhibition was held grandly in Moscow. As a long-term participant and key partner of the exhibition, Shaoxing Renhe Capsule Co., Ltd. once again made its appearance as a strategic exhibitor, marking the fifth consecutive year of showcasing the professional expertise and innovative achievements of China's medicinal capsule manufacturer to the rapidly growing Eurasian pharmaceutical market. This participation was not only a vital opportunity for Renhe Capsule’s annual exchange with the Russian market but also a testament to its enduring commitment to deepening its presence in the CIS region and promoting the upgrading of the local pharmaceutical industry.

At this exhibition, Renhe Capsule presented a product portfolio specifically optimized for the Russian-speaking market. Building on the trusted gelatin capsules and HPMC plant-based capsules, the company highlighted custom-sized capsules that comply with the latest regulations of the Eurasian Economic Union. During the event, representatives from many long-standing Russian pharmaceutical partners specially visited Renhe's booth, engaging in in-depth discussions with the technical team on topics such as upgrading existing products and collaborating on new project developments. "Cooperation with Renhe has become a stable part of our supply chain," remarked a senior procurement director from Moscow. "The innovations they bring each year consistently align with our evolving needs."

The Russian market has evolved from a "new market" to a "strategic market" for Renhe. After five years of cultivation and steady progress, Renhe Capsule has established a customer network encompassing over twenty leading pharmaceutical companies in the Russian market through continuous participation in exhibitions and technological investments. These achievements signify that Renhe Capsule has reached a new level in its localized service capabilities in the Eurasian market, consistently infusing innovative momentum into the development of the "Belt and Road" health industry with the meticulous quality of "Intelligent Chinese Manufacturing."